Washington, DC (June 14, 2018) – Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement applauding the Senate Judiciary Committee members for voting to advance the CREATES Act:
“The Healthcare Supply Chain Association (HSCA) applauds and thanks Chairman Grassley, Senator Leahy and all Senate Judiciary Committee members who voted to advance the CREATES Act for leading the effort to reduce prescription drug prices for patients. Americans rely on generic drugs to reduce costs and increase access to essential medications, and price spikes for commonly used drugs jeopardize patient access to care. HSCA will continue to advocate for policy solutions like the CREATES Act that lower drug prices, encourage competition and innovation in the marketplace, and end anti-competitive abuses utilized by some brand-name manufactures. We urge the Senate to pass the CREATES Act to help protect patient access to affordable prescription drugs for healthcare providers and the patients they serve.”Lear More
We, the undersigned, commend you for your leadership and commitment to reducing out-of-control prescription drug prices and stopping anti-competitive abuses that keep drug prices high. We are encouraged that the Senate Judiciary Committee has noticed a markup of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974). We thank you for your efforts to move this important piece of legislation through the Committee.Lear More
Comments of the Healthcare Supply Chain Association (HSCA) on Supported Lifetimes and Legacy Medical Devices
Advances in information technology and medical devices, and increasing interoperability of information systems, devices and services are improving patient care and creating efficiencies in the healthcare system. Medical devices are often life-sustaining or provide vital clinical functions that cannot be compromised without diminishing direct patient care. Accordingly, the availability, reliability, and safety of these devices is essential.Lear More
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration (DEA) proposed rule on annual opioid production limits.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as the vast majority of the 68,000+ long-term care facilities, surgery centers, clinics, and other healthcare providers.Lear More